Interpace Biosciences (IDXG) Reports Q1 EPS of $0.03

Interpace Biosciences (OTC: IDXG) reported Q1 EPS of $0.03. Revenue for the quarter came in at $9.03 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• BofA Securities Upgrades Nomura Holdings Inc. (8604:JP) (NMR) to Buy
• Lonza Group (LONN:SW) (LZAGY) PT Raised to CHF720 at RBC Capital